ALS patients losing time and hope as they wait for insurers to cover a pricey new drug
(By Ed Silverman for STAT) For the past two years, Sarah Benoit has been getting around with the help of
Read More(By Ed Silverman for STAT) For the past two years, Sarah Benoit has been getting around with the help of
Read More(By Richard Harris for NPR) The Food Drug Administration has approved a first-of-its-kind drug that reduces the number of migraines
Read More(By Ike Swetlitz and Erin Mershon for STAT) WHITE OAK, Md. — The House is set to take up a
Read More(By Shefali Luthra for Kaiser Health News) This week, Vermont passed a first-in-the-nation law that would facilitate the state’s importation of prescription
Read More(By Erin Mershon for STAT) Johnson & Johnson’s Actelion Pharmaceuticals, Celgene, and Gilead Life Sciences are all potentially blocking generic
Read More(By Alison Kodjak for NPR) When Celgene Corp. first started marketing the drug Revlimid to treat multiple myeloma in 2006,
Read MoreIn 2017, the Food and Drug Administration approved the first chimeric antigen receptor (CAR)-T cell therapies, now the Centers for
Read More(By Lev Facher for STAT) WASHINGTON — The Food and Drug Administration on Wednesday approved for the first time a
Read MoreWhen the President signed the Bipartisan Budget Act of 2018 on February 9th, this legislation affected those individuals with Medicare
Read More(By Richard Harris for NPR) Sometimes less may be better when it comes to treatment for breast cancer. A new
Read More